Press release
Heart failure Pipeline Insight 2023: Clinical Trials, Emerging Therapies, Latest FDA, EMA, PDMA Approval, and Companies involved by DelveInsight | Bayer, Juventas Therapeutics, Amgen, GlaxoSmithKline and Many Others
Heart failure Pipeline
Heart failure Overview:
Heart failure, also known as congestive heart failure refers to the condition when heart is not able to pump adequate blood to the body. In the absence of sufficient blood flow, all the major body functions are disrupted. Certain conditions, such as narrowed arteries in the heart (coronary artery disease) or high blood pressure, gradually leave the heart too weak or stiff to fill and pump efficiently. Heart failure can be diagnosed based on the medical and family history, a physical exam, and test results. Treating heart failure depends on the severity of the condition. Diagnostic tests include: electrocardiogram, chest X-Ray, echocardiography etc. Treatments usually include heart-healthy lifestyle changes, medicines, and ongoing care.
Know more about Heart failure Report, click here: https://www.delveinsight.com/report-store/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the Heart failure companies working in the market are:
• Eli Lilly and Company
• Bayer
• BioCardia
• Mesoblast Inc.
• Janssen Research & Development
• Pfizer
• Bristol-Myers Squibb
• Actelion Pharmaceuticals
• Tasly Pharmaceuticals
• Ionis Pharmaceuticals
• Innolife
• Imara Inc
• Bristol-Myers Squibb
• Stealth BioTherapeutics
• Bristol Myers Squibb
• Berlin Cures
• Bayer
• AstraZeneca
• Regeneron Pharmaceuticals
• GlaxoSmithKline
• SQ Innovation
• Recardio
• BIAL
• AstraZeneca
• Bristol Myers Squibb
• Imbria Pharmaceuticals
• Tenaya Therapeutics
• RibomicAnd Many Others
DelveInsight's Heart failure report covers around 90+ products under different phases of clinical development like:
• Late-stage Heart failure products (Phase III)
• Mid-stage Heart failure products (Phase II and Phase I/II)
• Early-stage Heart failure products (Phase I/II and Phase I) along with the details of
• Heart failure Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Request for Heart failure Pipeline sample report to know in detail about the Heart failure product segmentation: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of Heart failure Therapies:
• Finerenone (BAY94-8862)
• Omecamtiv Mecarbil
• ACRX-100
• GSK2798745
• LMI 1195-101
• Elamipretide
• FA relaxin
• BMS-986231
• Rexlemestrocel-L
• CardiAMP Cell Therapy
• And Many Others
Click here to know more about the Heart failure therapeutic assessment: https://www.delveinsight.com/report-store/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Current Heart failure Treatment Scenario and Heart failure Emerging Therapies:
• How many companies are developing Heart failure drugs?
• How many Heart failure drugs are developed by each company?
• How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Heart failure?
• What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the Heart failure therapeutics?
• What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Heart failure and their status?
• What are the key designations that have been granted to the emerging drugs?
Click here to know more about the recent developments in the heart failure domain: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents:
• Introduction
• Executive Summary
• Heart Failure: Overview
• Heart Failure Causes
• Heart Failure Mechanism of Action
• Heart Failure Signs and Symptoms
• Heart Failure Diagnosis
• Heart Failure Treatment
• Heart Failure Pipeline Therapeutics
• Comparative Analysis
• Heart Failure Therapeutic Assessment
• Assessment by Product Type
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
• Heart Failure - DelveInsight's Analytical Perspective
• Late Stage Products (Phase III)
• Comparative Analysis
• Tirzepatide: Eli Lilly and Company
• Product Description
• Research and Development
• Product Development Activities
• Drug profiles in the detailed report…..
• Mid Stage Products (Phase II)
• Comparative Analysis
• AZD-8601: AstraZeneca
• Product Description
• Research and Development
• Product Development Activities
• Drug profiles in the detailed report…..
• Early Stage Products (Phase I/II)
• Comparative Analysis
• Drug name: Company name
• Product Description
• Research and Development
• Product Development Activities
• Drug profiles in the detailed report…..
• Early Stage Products (Phase I)
• Comparative Analysis
• AZD-3427: AstraZeneca
• Product Description
• Research and Development
• Product Development Activities
• Drug profiles in the detailed report…..
• Preclinical and Discovery Stage Products
• Comparative Analysis
• RBM-003: Ribomic
• Product Description
• Research and Development
• Product Development Activities
• Drug profiles in the detailed report…..
• Inactive Products
• Comparative Analysis
• Heart Failure Key Companies
• Heart Failure Key Products
• Heart Failure Unmet Needs
• Heart Failure Market Drivers and Barriers
• Heart Failure - Future Perspectives and Conclusion
• Heart Failure Analyst Views
• Heart Failure Key Companies
• Appendix
Request for Detailed TOC: https://www.delveinsight.com/sample-request/heart-failure-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Central Serous Chorioretinopathy Market: https://www.delveinsight.com/report-store/central-serous-chorioretinopathy-market
• Conference Coverage Services: https://www.delveinsight.com/consulting/conference-coverage-services
• Generalized Pustular Psoriasis Market: https://www.delveinsight.com/report-store/generalized-pustular-psoriasis-gpp-market
• Hemorrhagic Cystitis Market: https://www.delveinsight.com/report-store/hemorrhagic-cystitis-market
• Menorrhalgia Market: https://www.delveinsight.com/report-store/menorrhalgia-market
• Ocular Motility Disturbance Market: https://www.delveinsight.com/report-store/ocular-motility-disturbance-market
• Post-bariatric Hypoglycemia Market: https://www.delveinsight.com/report-store/post-bariatric-hypoglycemia-market
• Thrombotic Microangiopathy Market: https://www.delveinsight.com/report-store/thrombotic-microangiopathy-tma-market
• Vascular Dementia Market: https://www.delveinsight.com/report-store/vascular-dementia-market
• Acute Heart Failure Ahf Market: https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market
• Acute Ischemic Stroke Ais Market: https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market
• Bartonellosis Market: https://www.delveinsight.com/report-store/bartonellosis-market
• Biliary Tract Carcinoma Market: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
• Chronic Idiopathic Urticaria Market: https://www.delveinsight.com/report-store/chronic-spontaneous-urticaria-market
• Epithelioid Sarcoma Market: https://www.delveinsight.com/report-store/epithelioid-sarcoma-market
• Glycogen Storage Disease Market: https://www.delveinsight.com/report-store/glycogen-storage-disease-market
• Hyperinsulinemic Hypoglycemia Market: https://www.delveinsight.com/report-store/congenital-hyperinsulinism-market
• Neurofibromatosis 2 Market: https://www.delveinsight.com/report-store/neurofibromatosis-type-2-market-insight
• Phosphoglucomutase Pgm 1 Deficiency Market: https://www.delveinsight.com/report-store/phosphoglucomutase-pgm-1-deficiency-market
• Polycythemia Vera Market: https://www.delveinsight.com/report-store/polycythemia-vera-market
• Refractory Chronic Cough Market: https://www.delveinsight.com/report-store/chronic-refractory-cough-market
• Vestibular Schwannoma Market: https://www.delveinsight.com/report-store/vestibular-schwannoma-market
• Advanced Hepatocellular Carcinoma With Cpb Liver Cirrhosis Market: https://www.delveinsight.com/report-store/advanced-hepatocellular-carcinoma-with-cpb-liver-cirrhosis-pipeline-insight
• Ankylosing Spondylitis Bekhterevs Disease Market: https://www.delveinsight.com/report-store/ankylosing-spondylitis-bekhterevs-disease-market
• Balloon Catheters Market Market: https://www.delveinsight.com/report-store/balloon-catheters-market
• Cellulitis Market: https://www.delveinsight.com/report-store/cellulitis-market
• Cerebral Vein Thrombosis Market: https://www.delveinsight.com/report-store/cerebral-vein-thrombosis-market
• Fibrocystic Breast Condition Market: https://www.delveinsight.com/report-store/fibrocystic-breast-condition-market
• Idiopathic Membranous Nephropathy Market: https://www.delveinsight.com/report-store/idiopathic-membranous-nephropathy-market
• Mydriasis Market: https://www.delveinsight.com/report-store/mydriasis-market
• Artificial Iris Market: https://www.delveinsight.com/report-store/artificial-iris-market
• Bronchopulmonary Dysplasia Market: https://www.delveinsight.com/blog/bronchopulmonary-dysplasia-treatment-market
• Chronic Gout Market: https://www.delveinsight.com/report-store/chronic-gout-market
• Dermal Erythema Market: https://www.delveinsight.com/report-store/dermal-erythema-market
• Dysthymia Market: https://www.delveinsight.com/report-store/dysthymia-market
• Spinal Stenosis Market: https://www.delveinsight.com/report-store/spinal-stenosis-devices-market
• Wegener S Granulomatosis/granulomatosis With Polyangiitis Market: https://www.delveinsight.com/report-store/wegeners-granulomatosis-market
Contact us
Ankit Nigam
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heart failure Pipeline Insight 2023: Clinical Trials, Emerging Therapies, Latest FDA, EMA, PDMA Approval, and Companies involved by DelveInsight | Bayer, Juventas Therapeutics, Amgen, GlaxoSmithKline and Many Others here
News-ID: 3142667 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…
